Expansions, Acquisitions, Global Partnerships, and Stock Updates - Analyst Notes on Dow Chemical, Monsanto, DuPont, Eastman, and CF Industries

Editor Note: For more information about this release, please scroll to bottom.

News provided by

Mar 06, 2014, 08:19 ET

NEW YORK, March 6, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding The Dow Chemical Company (NYSE: DOW), Monsanto Company (NYSE: MON), E I Du Pont De Nemours And Co (NYSE: DD), Eastman Chemical Company (NYSE: EMN), and CF Industries Holdings, Inc. (NYSE: CF). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

The Dow Chemical Company Analyst Notes

On February 26, 2014, stock of The Dow Chemical Company (Dow Chemical) rose 1.29%, to end at $47.83. Over the past three trading days, Dow Chemical's shares climbed 1.85%, while the S&P 500 gained 0.49% during that period. The full analyst notes on The Dow Chemical Company are available to download free of charge at:

http://www.AnalystsReview.com/03062014/DOW/report.pdf

Monsanto Company Analyst Notes

On February 20, 2014, Monsanto Company (Monsanto) reported that its subsidiary, The Climate Corporation, announced the acquisition of the soil analysis business line of Solum, Inc. (Solum), an agricultural technology company. According to Monsanto, the asset acquisition by the Company includes the Solum brand, soil testing intellectual property, the soil test lab in Ames, Iowa, and Solum's No-Wait Nitrate™ platform. The Company added that the Ames lab will continue to provide its highly accurate and reliable mail-in sample service to help customers measure and manage their soil fertility, and The Climate Corporation will continue to operate Solum's No-Wait Nitrate™ platform, which offers real-time measurement of soil nitrate levels from the edge of the field. According to Monsanto, The Climate Corporation has extended job offers to all Solum employees working in their soil testing business. Monsanto further stated that Solum's software business line will remain independent under its new brand, Granular, Inc. The full analyst notes on Monsanto Company are available to download free of charge at:

http://www.AnalystsReview.com/03062014/MON/report.pdf

E I Du Pont De Nemours And Co Analyst Notes

On February 25, 2014, E I Du Pont De Nemours And Co (DuPont), together with The Resolution Project, announced a broad global partnership to support young socially responsible leaders launching innovative social ventures. The Company stated that this partnership will focus on four areas of key importance: feeding the world, improving energy systems and supply, protecting people and the environment, and promoting STEM (Science, Technology, Engineering and Mathematics) education - wherein the Company will provide funding to support The Resolution Project's Fellowship offerings and seed funding for Fellow-led ventures. William D. Provine, Director of Science & Technology at DuPont, "DuPont is pleased to offer the most promising young leaders access to a pathway for action for their social ventures. We believe that our partnership with The Resolution Project will create sustainable change for years to come. DuPont is excited to play a critical role in strengthening this ecosystem and helping to make sure that Resolution Fellows have access to specific, relevant and deep support." The full analyst notes on E I Du Pont De Nemours And Co are available to download free of charge at:

http://www.AnalystsReview.com/03062014/DD/report.pdf

Eastman Chemical Company Analyst Notes

On February 25, 2014, Eastman Chemical Company (Eastman) announced an expansion of carboxylic acids capacity at its Longview, Texas, and Kingsport, Tennessee, facilities. Eastman stated that the additional capacity is expected to be completed in Q4 2014 and will add c.50 million pounds of carboxylic acids to support the increasing internal and external demand of the product. Chip Millican, Business Manager for Eastman's Organic Intermediates business unit (a part of the Specialty Fluids and Intermediates business segment), commented, "Internal demand for our acids ensures our commitment to long-term efficient production for both internal and external customers. These are important intermediate materials and we continue to invest in them. Additionally, our engineers have identified at least 20 million pounds of additional low cost capacity that could be implemented in the future as demand dictates." The full analyst notes on Eastman Chemical Company are available to download free of charge at:

http://www.AnalystsReview.com/03062014/EMN/report.pdf

CF Industries Holdings, Inc. Analyst Notes

On February 26, 2014, stock of CF Industries Holdings, Inc. (CF Industries) increased 0.56%, to close at $244.28. Over the past three trading days, CF industries' shares climbed 0.54%, while the Dow Jones Industrial Average gained 0.59% during the same period. The full analyst notes on CF Industries Holdings, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03062014/CF/report.pdf

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsCorner.com

SOURCE Analysts Review